Miist Therapeutics

Miist Therapeutics is developing a rapid-acting inhaler for smoking cessation and migraine treatment. Its unique technology delivers medication quickly through the lungs, providing faster relief compared to traditional methods. The inhaler's vape-like design also addresses psychological aspects of quitting smoking by mimicking the habitual act.

Buy Funded Startups lists

Funding Round: Seed

Funding Amount: $7M

Date: 04-Feb-2025

Investors: Refactor Capital, 1517 Fund, Freeflow Ventures

Markets: Healthtech, Pharmaceuticals, Biotechnology Research, Medical, Drug Delivery

HQ: Alameda, California, United States

Founded: 2019

Website: https://www.miisttherapeutics.com/

LinkedIn: https://www.linkedin.com/company/miisttherapeutics

Twitter:

Instagram: